|
HS Code |
171222 |
| Product Name | Hydrocortisone Acetate Injection Veterinary Grade API |
| Chemical Formula | C23H32O6 |
| Molecular Weight | 404.5 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Practically insoluble in water; freely soluble in alcohol and acetone |
| Purity | Typically ≥99% |
| Intended Use | Pharmaceutical raw material for Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Stability | Stable under recommended storage conditions |
| Storage Conditions | Store in a cool, dry place, protected from light |
| Cas Number | 50-03-3 |
| Pharmacological Class | Glucocorticoid corticosteroid |
| Route Of Administration | Oral, Injectable |
As an accredited Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Sealed HDPE container, 1 kg net, with tamper-evident lid, inner double polybag, labeled with batch details and storage instructions. |
| Shipping | Hydrocortisone Acetate Injection Veterinary Grade API is securely packed in sealed, tamper-evident containers compliant with international transport regulations. Shipped via temperature-controlled logistics to maintain product integrity, each consignment includes clear labeling, safety data sheets (SDS), and proper documentation, ensuring safe and timely delivery for tablets, injections, capsules, powders, granules, premix, or solution forms. |
| Storage | Store Hydrocortisone Acetate Injection (Veterinary Grade API) in a tightly sealed container, protected from light and moisture. Maintain storage at controlled room temperature, ideally between 15°C and 25°C (59°F–77°F). Keep away from incompatible substances and out of reach of unauthorized personnel. Ensure proper ventilation and label containers clearly for identification and safety compliance. |
|
Purity 99%: Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with purity 99% is used in oral tablet formulations, where it ensures consistent pharmacological efficacy and minimized impurities. Particle Size D90 ≤ 20 µm: Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with particle size D90 ≤ 20 µm is used in injectables, where it provides enhanced solubility and rapid absorption. Moisture Content ≤ 0.5%: Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with moisture content ≤ 0.5% is used in powder blends for premixes, where it ensures long-term stability and prevents degradation. Melting Point 220–224°C: Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with melting point 220–224°C is used in capsule manufacturing, where it guarantees thermal stability during encapsulation. Viscosity Grade Low: Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with low viscosity grade is used in solution preparations, where it facilitates ease of mixing and homogeneous dispersion. Stability Temperature up to 40°C: Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with stability temperature up to 40°C is used in veterinary field kits, where it maintains activity under varied storage conditions. Assay ≥ 98.5%: Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions with assay ≥ 98.5% is used in granule premix production, where it ensures precise dosage and regulatory compliance. |
Competitive Hydrocortisone Acetate Injection Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Walking through our production halls, the clean hum of fill-and-finish lines, the focus on quality control, and the daily involvement of our highly-trained formulation team remind me what separates a direct manufacturer from the trading crowd. When producing Hydrocortisone Acetate Injection Veterinary Grade API, the responsibility runs deep—quality goes beyond chemistry, reaching into the everyday well-being of livestock and companion animals. This isn’t about churning out bulk chemical. It’s about discipline at every stage, with eyes on the smallest details so veterinarians and animal pharma companies rely on a stable, safe input for their finished products.
Hydrocortisone Acetate, a corticosteroid with proven anti-inflammatory and immunosuppressive properties, addresses a broad range of conditions—from adrenal insufficiency to allergic reactions, shock, and even certain autoimmune disorders in animals. Our veterinary grade API reflects a focus on both pharmacological integrity and practical formulation: stable powder, crystalline appearance, high purity, and aligned with international monograph requirements. The typical model we ship for veterinary reconstitution and finished product manufacture offers a purity of no less than 99%, water content under 0.5%, and a surface area suited to rapid dispersion in appropriate excipient blends. Each batch undergoes validated processes for sterility, heavy metal testing, and particle analysis. Days are spent chasing down even minor deviations; it is never “good enough” until the numbers line up the way they should.
Traditionally, a manufacturer’s input ended at bulk supply, but expectations have changed. Partnering directly with global animal health firms means providing APIs that adapt to all common finished dosage forms: injectables, solid tablets, capsules, oral powders, water-soluble granules, premixes, and solutions. For injectable applications, we ensure low bioburden, micronized or pre-filtered lots, and robust solubility profiles. Tablet and capsule clients want APIs with controlled particle size distribution to aid tableting and dissolution. Water-dispersible powders and granules present their own challenges with flow and wettability, met by engineering the right lattice structure and particle morphology. Each adjustment here affects not just the lab, but the reliability of treatment on the farm or in the clinic.
Market entry remains tight for APIs meant for animal use—rightly so. We follow the blueprint set by key pharmacopeias, applying the strictest criteria to every batch. In countries with unique requirements, such as specific impurity thresholds or special analytical markers, we’ve worked with national animal health authorities to align our site, process, and documentation accordingly. Over the years, feedback from veterinary pharma formulators has prodded improvements in both analytical methods and packaging systems. Cold chain integrity for large container shipments and nitrogen blanketing for sensitive lots have been implemented by need, not by rote. Experience tracing back more than thirty years shows that regulatory shifts must be met head-on, so that veterinarians and producers are never left scrambling to reinterpret specs when a law changes.
Direct manufacturing control provides an edge that resellers rarely deliver: repeated validation, full batch traceability, committed response to out-of-spec issues, and swift integration of veterinary client feedback. Long-standing veterinary compounders and OEMs approach us with clear expectations—consistent dissolution, absence of off-odors or color, low endotoxin content, and, above all, reliability in the face of real-world animal health challenges. The conversations across our technical support desks often center on troubleshooting bottlenecks in solution stability, or hard lessons learned from earlier generic sources. In several documented instances, switching from non-specialized, generic hydrocortisone acetate to our veterinary grade input resolved recurring complaints of suspension separation or poor syringeability in field conditions.
Not all hydrocortisone acetate on the market carries veterinary suitability. Pharmaceutical (human) and industrial grades appear interchangeable at a glance but differ in key respects. Veterinary injectable formulations demand a level of sterility and bioburden control unmatched in industrial or food-use offerings. Particle size distribution requirements for tablet or capsule synthesis demand tight, reproducible ranges, avoiding issues with uneven dosing or poor excipient cohesion. Meanwhile, veterinary products must tolerate wider storage variances and rougher shipment conditions—our packaging lines treat cGMP cyclic loading and vibration controls as non-negotiables, not conveniences.
We supply both local veterinary compounders crafting small-volume specialty batches and large regional animal pharma manufacturers producing at scale. The needs sometimes look worlds apart, but shared priorities emerge: batch-to-batch repeatability, confidence that each package going out the door holds exactly the potency and purity specified, and lots documented so a batch issue in a finished product can trace back within hours—not days or weeks. Clients frequently require technical input on extending shelf life for compounded premixes or optimizing the stability of reconstituted injectable solutions. We draw on in-house stability studies—ranging from temperature cycling to accelerated light exposure—to advise with specifics, not guesses.
We’ve shipped into markets where cold chain infrastructure is inconsistent, and broad temperature swings are a reality. In response, we invested in heat-sealed, dual-barrier pouches and secondary container systems, labeled with actual batch stability results under common transport and storage conditions. In feedback from multiple field veterinarians, our materials have preserved activity better during extended storage in uncontrolled warehouse environments.
An API supplier is only as trusted as its worst batch. The best way to keep trust is not to let a bad batch leave the facility. Stringent in-process controls measure solubility at several time points, check for polymorphic changes, and screen for residual solvents both pre- and post-packaging. Automated filling lines record every weight and barcode, triggering full investigation if a container deviates from standard. Experience has highlighted that controlling airborne particle counts in blending rooms makes a real difference in end quality; regular audits verify filters and positive pressure systems aren't just installed, but operating within spec.
We’ve seen trends—shifts in preferred excipients, new delivery platforms like depot injectables, pressure from regulatory agencies for ever-lower impurity limits. Meeting these changes takes more than a certificate. It means bringing formulation and analytical chemists together, running extra validation lots, and investing in new equipment where needed. While capital spending doesn’t earn headlines, it underpins our ability to answer when a vet pharma client asks us for data on solubility curves in modified oil vehicles or compatibility with evolving capsule polymers.
One of our distinguishing assets is a technical support loop deeply integrated with both production and client QA teams. Real-time feedback cycles—from the farm, from pilot batch tableting lines, and from final product labs—show up on our shop floors. For example, a regional distributor flagged minor odor issues in compounded vet injectables. Our lab traced the issue to suboptimal solvent removal parameters and made specific process adjustments, verified with follow-up samples.
Another frequent topic is ease of blending across multiple applications. Hydrocortisone acetate destined for injectable suspension markets sometimes calls for finer-grain milling, but aggressive pursuit of micronization without watching for amorphous content can compromise shelf life. Through our process controls, we balance the needs for rapid dissolution in short-stay injectables and stability in chewable or extended-release dosage forms. Open lines to veterinary compounders ensure practical formulation recommendations—helping large and small buyers avoid costly rework or formulation downtime.
Emerging diseases, new livestock production systems, and evolving regulatory climates all place new pressures on animal health product manufacturers. Whether developing injectables for acute conditions, oral powders for chronic management, or combination preparations for integrated regimens, large firms and bespoke compounders often raise issues not detailed in generic guidelines. One client required hydrocortisone acetate suitable for a multi-species chewable, requiring not just chemical purity but zero detectable off-flavors despite variable veterinary excipient choices. We collaborated directly, shipping multiple pilot lots and refining process steps until the product met both technical specs and taste masking profiles.
Another challenge: injectable products designed for high-volume handling in production animal settings must maintain suspension in large reservoirs without settling, even under variable climactic conditions. Our formulation chemists, working from our own stability findings, can recommend both particle calibrations and suspension agents compatible with our API—again, leveraging field experience rather than ballpark figures.
In our own experience, true reliability grows from partnerships: working side-by-side with veterinary pharmaceutical firms, sharing clear data, not just shipping boxes. We’ve built production infrastructure supporting both large batch, multi-tonne contracts for regional animal health companies and tailored small-lot supplies for local compounding pharmacies. Traceable batch records, full GMP documentation, and responsive, real-world technical support form the core of our offering.
Direct collaboration means we’re constantly fielding new formulation goals. In recent years, shifts in livestock production—such as large-scale poultry and aquaculture operations—have required adjustments to packaging and solubility profiles tailored to new dosing and delivery systems. Veterinary oral solutions used in livestock water systems, for example, need APIs free of agglomerates and with rapid, complete rehydration. Our hydrocortisone acetate, via continuous feedback from partner plants, maintains stability in these demanding scenarios, supporting disease management where access to hands-on veterinary support runs thin.
Animal health outcomes depend on product consistency, and achieving that relies less on marketing claims and more on the day-to-day execution at the manufacturer level. Having control over synthesis, drying, milling, packaging, and quality checks makes a tangible difference—especially when products reach the realities of veterinary practice. Every year, we review the performance of our Hydrocortisone Acetate Veterinary Grade API across diverse end-use cases, evaluating not only laboratory analytics but long-term, on-farm results.
End-to-end manufacturing provides a feedback loop unavailable to third-party brokers or speculative traders. Constant communication among our QA teams, production leads, and support chemists translates industry shifts or client-specific challenges into process improvements in days or weeks, not quarters or years. We’ve taken direct action after feedback—refining filtration requirements or updating primary container materials—based not on abstract regulatory trends, but on the real needs of veterinarians, livestock producers, and finished product manufacturers.
Over three decades serving animal health, we find that commitment to manufacturing quality shines brightest not in marketing language, but in the day-in, day-out evidence: repeat orders from longstanding partners, favorable audits by regulatory authorities, and the unbroken chain of batch certifications that veterinary finished product manufacturers demand with each new container. Our reputation builds not from a single product launch, but from continuing to meet requested spec—even under supply chain stress, regulatory change, or fluctuations in raw material markets. Firms producing everything from veterinary injectable suspensions to multi-species premixes return year after year because the product—and the people behind it—responds to their actual needs.
Manufacturing Hydrocortisone Acetate Injection Veterinary Grade API stands as an exercise in precision, discipline, and attention to both science and the everyday pressures facing animal health professionals. Real-world differences between veterinary grade and other sources stem not just from the label, but from experience-backed, field-tested focus on every variable that matters to finished product quality—sterility, particle size, dissolution, stability, packaging, and traceability. Saying these things is easy; consistently delivering on them, batch after batch and year after year, proves far more difficult.
For the veterinarian administering life-saving injectables in a remote clinic or the animal health manufacturer building new solutions for commercial farming, the value chain begins at the point of synthesis and ends with animal well-being. Backed by deep experience, direct control, and the willingness to learn from every batch shipped and every client call, we support those goals as more than a supplier. The difference comes down not to a product catalogue, but to the real assurance built into every lot delivered to the animal health market.